Jonathan Colon is currently a Scientist II, Formulation Development at Seres Therapeutics, focusing on designing Drug Product images for both Adults and Pediatric patients. Previously, Jonathan held roles at companies such as Assembly Biosciences, Inc., Bristol-Myers Squibb, and Celgene, working in Drug Product Development. Jonathan's academic background includes a PhD in Chemical and Biochemical Engineering from Rutgers University, where their research focused on developing materials for protecting military personnel against chemical warfare agents. Jonathan also holds a Master's degree in Chemical and Biochemical Engineering from Rutgers University and a Bachelor's degree in Chemical Engineering from the University of Puerto Rico-Mayaguez.
Sign up to view 0 direct reports
Get started